Rigel Pharmaceuticals, Inc. (NasdaqGS:RIGL) is looking for acquisitions. Raul Rodriguez, Chief Executive Officer said, "We're looking at other in-license and acquisition opportunities that fit within our portfolio and continue to drive the top line of the product of our sales, so that in the future, it's far larger than I shared with you today".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | 0.00% | +1.85% | -24.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.14% | 193M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RIGL Stock
- News Rigel Pharmaceuticals, Inc.
- Rigel Pharmaceuticals Seeks Acquisitions